NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Sinovac Biotech Co Ltd


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Latest Report on China's Pharmaceuticals and Healthcare Industry Now Available
2009 NOV 16 ... State Food and Drug Administration (SFDA) approved the world's first swine flu vaccine, Sinovac Biotech's Panflu. As is the norm with newly-introduced pandemic preventatives, the ... Influenza Vaccines, Pandemics, Pharmaceuticals, Regulatory Actions, Sinovac Biotech Co. Ltd., Therapies, Therapy, Treatment, Vaccination, Research and Markets Ltd. ...
Subject: Research and Markets Ltd
Price: $3.00
*
MarketsandMarkets: Global H1N1 2009 Influenza Vaccine Market Worth US$ 7,028 Million By 2011
2009 NOV 2 ... in this market are GlaxoSmithKline, Novartis, CSL, MedImmune, Sanofi-Pasteur, Solvay, Sinovac Biotech and Hualun Biologicals. The global H1N1 2009 Influenza vaccine ...
Subject: Flu Vaccines
Price: $3.00
*
Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
2009 AUG 17 ... Sinovac Biotech Ltd. (NYSE AMEX: SVA), a leading provider of vaccines in China, announced that ... Immunization, Influenza Vaccines, Pediatric Vaccines, Pediatrics, Sinovac Biotech Co. Ltd., Therapy, Treatment, U.S. Food and Drug Administration, Vaccination, Flu Vaccine, ...
Subject: Flu Vaccines
Price: $3.00
*
Sinovac Adjourns 2008 Annual General Meeting
2009 JUL 27 ... Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, ... Biotech Ltd., Biotechnology Business, Biotechnology Company, Vaccines, Sinovac Biotech Co. Ltd. This article was prepared by Biotech Business Week editors from staff ...
Subject: Sinovac Biotech Ltd.
Price: $3.00
*
Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea
2009 SEP 14 ... Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of biopharmaceutical products in ... Marketing and Licensing Agreements, Pharmaceuticals, Regulatory Actions, Sinovac Biotech Co. Ltd., Therapies, U.S. Food and Drug Administration, Vaccines, Sinovac Biotech Ltd. ...
Subject: Vaccines
Price: $3.00
*
Sinovac Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza a (H1N1)
2009 AUG 3 ... Sinovac Biotech Ltd. (NYSE AMEX: SVA), a leading provider of vaccines in China, announced that ... Research, Drug Development, Flu, Immunization, Influenza, Pandemics, Sinovac Biotech Co. Ltd., Therapy, Treatment, Vaccines, Sinovac Biotech Ltd. This article was ...
Subject: Pandemics
Price: $3.00
*
Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine
2009 SEP 21 ... Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of vaccines in China, announced that ... Business, Biotechnology Company, Pharmaceuticals, Regulatory Actions, Sinovac Biotech Co. Ltd., Vaccines, Sinovac Biotech Ltd. This article was prepared by Biotech ...
Subject: Vaccines
Price: $3.00
*
Sinovac Obtains Production License for H1N1 Vaccine
2009 SEP 14 ... Sinovac Biotech Ltd. (NYSE:SVA), a leading provider of biopharmaceutical products in China, ... Company, Drugs, FDA, Immunization, Pharmaceuticals, Regulatory Actions, Sinovac Biotech Co. Ltd., Therapies, U.S. Food and Drug Administration, Vaccines, Sinovac Biotech Ltd. ...
Subject: Immunization
Price: $3.00
*
Sinovac Obtains Second Order of H1N1 Vaccine from Chinese Central Government
2009 OCT 12 ... Sinovac Biotech Ltd. (NYSE:SVA), a leading provider of biopharmaceutical products in China, ... Biotechnology Company, Drugs, FDA, Immunization, Pharmaceuticals, Sinovac Biotech Co. Ltd., Therapies, Therapy, Treatment, U.S. Food and Drug Administration, Vaccination, ...
Subject: Vaccines
Price: $3.00
*
Sinovac Obtains Third H1N1 Vaccine Order from Chinese Central Government
2009 NOV 9 ... Sinovac Biotech Ltd. (NYSE:SVA), a leading provider of biopharmaceutical products in China, ... Biotechnology Business, Biotechnology Company, Drugs, Pharmaceuticals, Sinovac Biotech Co. Ltd., Therapies, Vaccines, Sinovac Biotech Ltd. This article was prepared ...
Subject: Vaccines
Price: $3.00
*
Sinovac Receives Certificate of Approval to Distribute Panflu (H5N1) Vaccine in Hong Kong
2009 NOV 1 ... Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, ... Bird Flu, Flu Vaccines, Immunization, Influenza Vaccines, Pandemics, Sinovac Biotech Co. Ltd., Vaccination, Sinovac Biotech Ltd. This article was prepared by ...
Subject: Vaccines
Price: $3.00
*
Sinovac Receives Certificate of Approval to Distribute PANFLU.1 (H1N1) in Mexico
2009 NOV 2 ... Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, ... Marketing and Licensing Agreements, Pandemics, Pharmaceuticals, Sinovac Biotech Co. Ltd., Therapies, Vaccination, Sinovac Biotech Ltd. This article was ...
Subject: Vaccines
Price: $3.00
*
Sinovac Receives Revised Approvals for Panflu
2009 JUL 13 ... Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, ... Immunization, Influenza Vaccines, Pandemics, Regulatory Actions, Sinovac Biotech Co. Ltd., U.S. Food and Drug Administration, Vaccination, Flu Vaccine, Sinovac Biotech Ltd. ...
Subject: Flu Vaccines
Price: $3.00
*
Sinovac Reports Top-Line Preliminary Results of H1N1 Vaccine Clinical Trials
2009 AUG 31 ... Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of vaccines in China, announced ... Trial Research, FDA, Flu Vaccines, Immunization, Influenza Vaccines, Sinovac Biotech Co. Ltd., Therapy, Treatment, U.S. Food and Drug Administration, Vaccination, Sinovac ...
Subject: Adverse Drug Reactions
Price: $3.00
*
Sinovac Reports Unaudited Second Quarter 2009 Financial Results
2009 AUG 31 ... Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, ... Pediatric Vaccines, Pediatrics, Public Health, Regulatory Actions, Sinovac Biotech Co. Ltd., Vaccination, Vaccine Development, Viral Research, Virology, Flu Vaccine, Sinovac ...
Subject: Flu Vaccines
Price: $3.00
*
Sinovac to Present at 2009 UBS Global Life Sciences Conference
2009 SEP 28 ... Sinovac Biotech Ltd. (NYSE:SVA), a leading provider of biopharmaceutical products in China, ... Biotech Ltd., Biopharmaceuticals, Drugs, Therapies, Pharmaceuticals, Sinovac Biotech Co. Ltd., Biotechnology Business, Biotechnology Company This article was ...
Subject: Sinovac Biotech Ltd.
Price: $3.00
*
Sinovac to Transfer Stock Exchange Listing to NASDAQ Global Market
2009 NOV 16 ... Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, ... Keywords: Sinovac Biotech Ltd., Vaccines, Biotechnology, Sinovac Biotech Co. Ltd., Biotechnology Business, Biotechnology Company This article was ...
Subject: Sinovac Biotech Ltd.
Price: $3.00
*
Sinovac Wins Beijing Public Health Bureau's Bid to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
2009 SEP 7 ... Sinovac Biotech Ltd. (NYSE:SVA), a leading provider of biopharmaceutical products in China, ... Immunization, Influenza Vaccines, Pharmaceuticals, Public Health, Sinovac Biotech Co. Ltd., Therapies, Vaccination, Flu Vaccine, Sinovac Biotech Ltd. This ...
Subject: Flu Vaccines
Price: $3.00
*
Weekly Digest's Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 'Swine Flu' Outbreak
2009 NOV 1 ... "Swine Flu" Outbreak, including updated outlooks for Gilead Sciences (NASDAQ:GILD), Sinovac Biotech (AMEX:SVA), Dynavax Technologies (NASDAQ:DVAX), Hemispherx BioPharma (AMEX:HEB), ... Inc., Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Sinovac Biotech Co. Ltd., Therapies, Indie Research Advisors Llc. This article was prepared by ...
Subject: Pharmaceuticals
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login